{
    "nctId": "NCT02550028",
    "officialTitle": "Levetiracetam Treatment of Neonatal Seizures: A Multi-Centre Randomized Blinded Controlled Study of the Efficacy of Oral Levetiracetam as First Line Treatment for Neonatal Seizures in China",
    "inclusionCriteria": "Neonatal seizure occurred and was proved by EEG according to abnormal discharge of brain. one or more of the following :\n\n1. Male or female term baby with gestational \\>37 weeks and postnatal age \\< or= 28 days\n2. Birthweight \\>2500g\n3. Written informed consent of parent or guardian\n* Must have maximum age of 28 Days",
    "exclusionCriteria": "1. Babies who have been close to death\n2. Seizure occurred by metabolic factors (hypoglycemia, hypocalcemia, electrolyte disorder)\n3. Babies who have received phenobarbitone or any other anticonvulsive medication before hospitalization\n4. Abnormal renal function"
}